1. Home
  2. JFR vs NNNN Comparison

JFR vs NNNN Comparison

Compare JFR & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Floating Rate Income Fund

JFR

Nuveen Floating Rate Income Fund

HOLD

Current Price

$7.93

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$32.70

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JFR
NNNN
Founded
2004
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
JFR
NNNN
Price
$7.93
$32.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
621.7K
35.5K
Earning Date
01-01-0001
04-28-2026
Dividend Yield
11.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
N/A
$6,920,153.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$525.34
Revenue Growth
N/A
N/A
52 Week Low
$7.61
$5.18
52 Week High
$8.82
$55.65

Technical Indicators

Market Signals
Indicator
JFR
NNNN
Relative Strength Index (RSI) 56.73 49.35
Support Level $7.79 $30.08
Resistance Level $8.00 $43.00
Average True Range (ATR) 0.06 4.23
MACD 0.00 -0.44
Stochastic Oscillator 71.74 32.68

Price Performance

Historical Comparison
JFR
NNNN

About JFR Nuveen Floating Rate Income Fund

Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income. The fund invests a majority of its managed assets in secured Senior Loans and unsecured Senior Loans, with an average duration of one year or less, in which unsecured Senior Loans will be, at the time of investment, investment grade quality.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: